Cognition clinical trials

Explore recruiting cognition clinical trials.

Recruiting cognition studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cognition trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ALaDIN - Use of low doses of interleukin-2 in autism spectrum disorders

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Placebo-Controlled, Double-Blind Study of XPro™ in Patients with Early Alzheimer’s Disease with Biomarkers of Inflammation

Poland, France, Spain, Germany, Czechia, Slovakia

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective pilot study of L-dopa treatment in patients with a neurodevelopmental disorder linked to a pathogenic variant of the CTNNB1 gene

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Biomarkers of the locus coeruleus nucleus: links with early tau pathology, cognition and AD risk. LocusTau

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicentre, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Effect of a 30-week Caffeine Treatment on Cognition in Alzheimer's Disease at Beginning to Moderate Stages. Effect of CAFeine on Cognition in Alzheimer's Disease ( CAFCA )

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Diving into the noradrenergic system : Role of the alpha2C-adrenergic receptors NA2C-TEP-IRM

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Cognition trials by city

Cognition in Toronto Cognition in Vancouver Cognition in Montreal Cognition in Calgary Cognition in Edmonton Cognition in Ottawa Cognition in Winnipeg Cognition in Quebec City Cognition in Hamilton Cognition in Kitchener Cognition in London Cognition in Halifax Cognition in New York Cognition in Los Angeles Cognition in Chicago Cognition in Houston

Cognition clinical trials

Recruiting cognition studies right now

Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment

Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)

Frequency of Interrupting Sitting and Cognitive Function

Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment

7T Amygdala and Citalopram Study

Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation

12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being

Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.

Adherence by Music to Exercise in Dementia: Group Therapy

A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment

Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Also recruiting in Europe

ALaDIN - Use of low doses of interleukin-2 in autism spectrum disorders

A Randomized, Placebo-Controlled, Double-Blind Study of XPro™ in Patients with Early Alzheimer’s Disease with Biomarkers of Inflammation

Prospective pilot study of L-dopa treatment in patients with a neurodevelopmental disorder linked to a pathogenic variant of the CTNNB1 gene

Biomarkers of the locus coeruleus nucleus: links with early tau pathology, cognition and AD risk. LocusTau

Multicentre, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Effect of a 30-week Caffeine Treatment on Cognition in Alzheimer's Disease at Beginning to Moderate Stages. Effect of CAFeine on Cognition in Alzheimer's Disease ( CAFCA )

Diving into the noradrenergic system : Role of the alpha2C-adrenergic receptors NA2C-TEP-IRM

Cognition trials by city

Other conditions